Financials in USD. Standardized financial statements.
A compact view of how Nova Leap Health Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $32.02M | $25.76M | $26.18M | $28.21M | $21.28M | $17.31M | $17.40M | $10.36M | $1.06M | $39,991 |
| Revenue Growth? | +24.3% | -1.6% | -7.2% | +32.5% | +22.9% | -0.5% | +68.0% | +877.7% | +2550.2% | 0.0% |
| Cost of Revenue? | $20.16M | $15.87M | $16.41M | $18.23M | $14.07M | $11.44M | $11.56M | $7.04M | $693,945 | $24,550 |
| Gross Profit? | $11.85M | $9.89M | $9.77M | $9.98M | $7.21M | $5.87M | $5.84M | $3.32M | $365,900 | $15,441 |
| Gross Margin? | +37.0% | +38.4% | +37.3% | +35.4% | +33.9% | +33.9% | +33.6% | +32.0% | +34.5% | +38.6% |
| Operating Expenses? | $10.73M | $9.02M | $9.31M | $11.04M | $3.32M | $4.06M | $5.96M | $4.08M | $1.23M | $481,247 |
| Operating Income? | $1.13M | $863,712 | $460,152 | -$1.06M | -$1.23M | -$396,078 | -$112,830 | $763,737 | -$907,150 | -$515,240 |
| EBITDA? | $1.97M | $1.14M | -$336,135 | $366,627 | $3.74M | $1.15M | $142,668 | -$284,937 | -$899,664 | -$504,953 |
| Income Before Tax | -$134,362 | $1.81M | -$1.37M | -$1.21M | $2.47M | $125,517 | -$951,114 | -$1.04M | -$925,861 | -$517,575 |
| Income Tax Expense | $58,825 | $433,542 | -$311,313 | -$370,816 | $712,521 | -$1.13M | $104,701 | -$79,317 | -$74,252 | -$28,056 |
| Net Income? | -$193,187 | $1.38M | -$1.05M | -$835,745 | $1.76M | $1.26M | -$1.06M | -$961,271 | -$851,609 | -$489,519 |
| EPS? | $-0.00 | $0.02 | $-0.01 | $-0.01 | $0.02 | $0.02 | $-0.02 | $-0.02 | $-0.04 | $-0.04 |
| Diluted EPS? | $-0.00 | $0.02 | $-0.01 | $-0.01 | $0.02 | $0.02 | $-0.02 | $-0.02 | $-0.04 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality